Dr. Verma on HER2 Testing and the Utility of Ki67

Sunil Verma, MD, MSEd, FRCPC, associate professor, University of Toronto, chair, Breast Medical Oncology, Sunnybrook Odette Cancer Centre, comments on HER2 testing and the utility of Ki67. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

• #education
• #targeted_oncology
• #oncology
• #cancer
• #breast_cancer_disease_or_medical_condition